Clinical analysis of 12 cases of acute exogenous lipoid pneumonia in children
Abstract
Objective To explore the clinical characteristics and diagnosis and treatment process of acute exogenous lipoid pneumonia (AELP) in children, in order to improve treatment efficacy and prognosis. Method This study retrospectively analyzed the clinical data and treatment process of patients with AELP admitted to the Intensive Care Medicine Department of Hebei Children’s Hospital from January 2017 to October 2025. Results 1.This study collected 12 patients, according to the interval between exposure to oil substances and hospitalization,patients with a delay of more than 12 h were classified as the delayed visit group, while those with a delay of less than or equal to 12 h were classified as the early visit group.Compared with the early visit group, the delayed visit group had significantly lower oxygenation score, higher inflammatory markers (WBC, CRP, LDH), and longer hospital stays (all P 7 days was lower than that of children with hospitalization time ≤ 7 days(P 12 h) was associated with a higher likelihood of secondary infection, greater treatment difficulty, and longer hospital stay.Monitoring oxygenation scores upon admission might serve as a preliminary predictor for longer hospital stays, pending validation in larger studies. Fiberoptic bronchoscopy combined with corticosteroid and nebulization therapy was used, and most children had a good prognosis.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 12 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.